Table 1

Overview of the distribution of patients who achieved drug-free remission during 5 years of follow-up in the four treatment groups

Sequential monotherapy (n=126)Step-up therapy (n=121)Initial combination with prednisone (n=133)Initial combination with infliximab (n=128)
Drug-free ever31242436
Still drug-free at 5 years14 (45)14 (58)10 (42)21 (58)
Restarted DMARD monotherapy15 (48)9 (38)14 (58)15 (42)
Lost to follow-up2 (6)1 (4)0 (0)0 (0)
  • Data are presented as n (%).

  • The number of patients who remained drug-free until 5 years of follow-up and who restarted DMARD monotherapy are shown; 3/115 patients were lost to follow-up.

  • DMARD, disease-modifying antirheumatic drug.